The Valley Desk

ArticleClinical breast cancerPublished

Clinical Utility of [18F]Fluoroestradiol PET/CT to Guide Second Line Treatment Decision in ER-Positive HER2-Negative Metastatic Breast Cancer After Progression on First Line Endocrine Therapy

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Hospital of the University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Clinical breast cancer
Published
Subject terms
Humans; Breast Neoplasms; Disease Progression; Estradiol; Receptors, Estrogen; Antineoplastic Agents, Hormonal; Radiopharmaceuticals; Prospective Studies; Adult; Aged; Middle Aged; Female
PubMed ID
42892305
Added to directory
Source checked

Report a correction or request removal